Infinimmune
Human-derived antibody medicines
United States · $12.0M raised
- Business Model
- B2B
- Website
- infinimmune.com
- Total Funding
- $12.0M
- Last Round
- $12.0M SeedDec 2022
- Rounds
- 1
About
Biotech company developing human-derived antibody medicines using the world's largest paired antibody sequence database.
Summary
Infinimmune is a Biotech company based in United States. It has raised $12.0M in total across 1 round, most recently a $12.0M Seed round in Dec 2022. Investors include Playground Global, Axial Partners and Civilization Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...